Market Closed -
Singapore S.E.
05:04:12 2024-06-21 EDT
|
5-day change
|
1st Jan Change
|
0.24
SGD
|
0.00%
|
|
-2.04%
|
-9.43%
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
793.7
|
189.7
|
535.2
|
550.4
|
500.6
|
-
|
-
|
Enterprise Value (EV)
1 |
793.7
|
189.7
|
535.2
|
550.4
|
893.6
|
891.6
|
889.6
|
P/E ratio
|
17.3
x
|
-0.53
x
|
16.7
x
|
-
|
10.4
x
|
9.6
x
|
-
|
Yield
|
8.64%
|
17.7%
|
-
|
-
|
10%
|
10.8%
|
11.3%
|
Capitalization / Revenue
|
6.88
x
|
2.38
x
|
-
|
5.07
x
|
4.81
x
|
4.59
x
|
4.43
x
|
EV / Revenue
|
6.88
x
|
2.38
x
|
-
|
5.07
x
|
8.59
x
|
8.18
x
|
7.87
x
|
EV / EBITDA
|
7.93
x
|
3.06
x
|
-
|
-
|
9.51
x
|
9.1
x
|
-
|
EV / FCF
|
8,027,248
x
|
3,795,768
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
0.93
x
|
0.41
x
|
-
|
-
|
0.8
x
|
0.8
x
|
-
|
Nbr of stocks (in thousands)
|
797,675
|
807,206
|
2,058,581
|
2,076,925
|
2,085,827
|
-
|
-
|
Reference price
2 |
0.9950
|
0.2350
|
0.2600
|
0.2650
|
0.2400
|
0.2400
|
0.2400
|
Announcement Date
|
1/29/20
|
1/14/21
|
3/28/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
115.3
|
79.62
|
-
|
108.6
|
104
|
109
|
113
|
EBITDA
1 |
100.1
|
61.94
|
-
|
-
|
94
|
98
|
-
|
EBIT
1 |
100.1
|
61.94
|
-
|
-
|
89
|
93
|
-
|
Operating Margin
|
86.79%
|
77.79%
|
-
|
-
|
85.58%
|
85.32%
|
-
|
Earnings before Tax (EBT)
1 |
75.39
|
-358.2
|
-
|
-
|
67
|
72
|
-
|
Net income
1 |
48.92
|
-352.4
|
33.58
|
63.34
|
48
|
52
|
-
|
Net margin
|
42.43%
|
-442.62%
|
-
|
58.34%
|
46.15%
|
47.71%
|
-
|
EPS
2 |
0.0574
|
-0.4433
|
0.0156
|
-
|
0.0230
|
0.0250
|
-
|
Free Cash Flow
|
98.87
|
49.98
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
85.76%
|
62.77%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
98.81%
|
80.69%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
202.13%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0860
|
0.0415
|
-
|
-
|
0.0240
|
0.0260
|
0.0272
|
Announcement Date
|
1/29/20
|
1/14/21
|
3/28/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
393
|
391
|
389
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
4.181
x
|
3.99
x
|
-
|
Free Cash Flow
|
98.9
|
50
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.17%
|
6.79%
|
-
|
-
|
15.5%
|
16.7%
|
17.9%
|
ROA (Net income/ Total Assets)
|
3.41%
|
3.68%
|
-
|
-
|
8%
|
8.7%
|
9.3%
|
Assets
1 |
1,433
|
-9,564
|
-
|
-
|
600
|
597.7
|
-
|
Book Value Per Share
2 |
1.070
|
0.5700
|
-
|
-
|
0.3000
|
0.3000
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
-
|
0.0300
|
0.0300
|
0.0300
|
Capex
1 |
-
|
-
|
-
|
-
|
2
|
2
|
2.3
|
Capex / Sales
|
-
|
-
|
-
|
-
|
1.92%
|
1.83%
|
2.04%
|
Announcement Date
|
1/29/20
|
1/14/21
|
3/28/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
0.24
SGD Average target price
0.29
SGD Spread / Average Target +20.83% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.43% | 370M | | +0.58% | 20.23B | | -3.76% | 13.64B | | +7.70% | 8.08B | | -5.86% | 6.08B | | +11.22% | 3.6B | | +2.87% | 3.36B | | -10.13% | 2.9B | | +19.61% | 2.89B | | -1.93% | 2.89B |
Healthcare REITs
|